IPP Bureau
Aptar Digital Health acquires Healint to broaden neurology portfolio
By IPP Bureau - February 23, 2024
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Jupiter Life Line Hospitals acquires land in Bibvewadi on lease
By IPP Bureau - February 23, 2024
Moderna posts Q4 2023 revenue at US$ 2.8 billion
By IPP Bureau - February 23, 2024
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students
By IPP Bureau - February 22, 2024
We are achieving the target of developed India by making our young children healthy today
Dr Mandaviya addresses WHO’s public launch event of GIDH
By IPP Bureau - February 22, 2024
Global Initiative on Digital Health (GIDH) was launched by the WHO and the Government of India during the G20 Health Working Group meeting in Gandhinagar last year
Pfizer and AIF’s Project Parivartan demonstrates progress in addressing antimicrobial resistance
By IPP Bureau - February 22, 2024
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
Evolving digital landscape within India's healthcare sector: HealthComms 2024 Report
By IPP Bureau - February 22, 2024
These digital avenues have not only revolutionized patient care but also opened up new opportunities for HCPs to build thought leadership in their respective fields
PM Modi inaugurates AIIMS Jammu
By IPP Bureau - February 21, 2024
The fast pace of construction of AIIMS Jammu whose foundation stone laying to inauguration took only 5 years highlights the commitment of the Government
Ayush Ministry to launch project of health screening and management through ayurvedic interventions
By IPP Bureau - February 21, 2024
The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.
Mandaviya inaugurates Vivekananda Cancer & Super Speciality Extension Hospital in Latur
By IPP Bureau - February 21, 2024
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
AstraZeneca completes acquisition of Icosavax
By IPP Bureau - February 21, 2024
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
Scandron receives India's first logistics drone type-certification from DGCA
By IPP Bureau - February 20, 2024
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
European Commission approves Pfizer’s Velsipity for patients with moderately to severely active ulcerative colitis
By IPP Bureau - February 20, 2024
VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU
Biocon included in S&P Global Sustainability Yearbook 2024
By IPP Bureau - February 20, 2024
Sustainability is integral to Biocon's business purpose
Briefs: IOL Chemicals and Pharmaceuticals and Auro Peptides
By IPP Bureau - February 20, 2024
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
